位置:首页 > 蛋白库 > CCNQ_HUMAN
CCNQ_HUMAN
ID   CCNQ_HUMAN              Reviewed;         248 AA.
AC   Q8N1B3; Q2I380; Q330J9; Q96IU5; Q9BUU1;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 2.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Cyclin-Q;
DE   AltName: Full=CDK10-activating cyclin;
DE   AltName: Full=Cyclin-M;
DE   AltName: Full=Cyclin-related protein FAM58A;
GN   Name=CCNQ {ECO:0000312|HGNC:HGNC:28434}; Synonyms=FAM58A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-183.
RC   TISSUE=B-cell, Blood, Kidney, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-228 (ISOFORM 2).
RA   Lin L., Nong W., Zhou G., Ke R., Shen C., Zhong G., Liang M., Tang Z.,
RA   Huang B., Li H., Yang S.;
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 52-130 (ISOFORM 1).
RA   Johne C., Tschop K., Engeland K.;
RT   "Cyclin M.";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, INTERACTION WITH SALL1, AND INVOLVEMENT IN STAR.
RX   PubMed=18297069; DOI=10.1038/ng.86;
RA   Unger S., Boehm D., Kaiser F.J., Kaulfuss S., Borozdin W., Buiting K.,
RA   Burfeind P., Boehm J., Barrionuevo F., Craig A., Borowski K.,
RA   Keppler-Noreuil K., Schmitt-Mechelke T., Steiner B., Bartholdi D.,
RA   Lemke J., Mortier G., Sandford R., Zabel B., Superti-Furga A., Kohlhase J.;
RT   "Mutations in the cyclin family member FAM58A cause an X-linked dominant
RT   disorder characterized by syndactyly, telecanthus and anogenital and renal
RT   malformations.";
RL   Nat. Genet. 40:287-289(2008).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   FUNCTION, MISCELLANEOUS, AND INTERACTION WITH CDK10.
RX   PubMed=24218572; DOI=10.1073/pnas.1306814110;
RA   Guen V.J., Gamble C., Flajolet M., Unger S., Thollet A., Ferandin Y.,
RA   Superti-Furga A., Cohen P.A., Meijer L., Colas P.;
RT   "CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is
RT   deficient in STAR syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:19525-19530(2013).
CC   -!- FUNCTION: Activating cyclin for the cyclin-associated kinase CDK10.
CC       {ECO:0000269|PubMed:18297069, ECO:0000269|PubMed:24218572}.
CC   -!- SUBUNIT: Associates with CDK10 to promote its kinase activity.
CC       Interacts with SALL1. {ECO:0000269|PubMed:18297069,
CC       ECO:0000269|PubMed:24218572}.
CC   -!- INTERACTION:
CC       Q8N1B3; Q15131-1: CDK10; NbExp=7; IntAct=EBI-3925043, EBI-11507283;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N1B3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N1B3-2; Sequence=VSP_034527;
CC   -!- DISEASE: Toe syndactyly, telecanthus, and anogenital and renal
CC       malformations (STAR) [MIM:300707]: A syndrome characterized by anal,
CC       genital and renal tract anomalies, facial dysmorphism and syndactyly.
CC       Features include anal stenosis, a rectovaginal fistula, clitoral
CC       hypertrophy, a pelvic right kidney, toe syndactyly, and telecanthus.
CC       {ECO:0000269|PubMed:18297069}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Silencing with siRNAs phenocopies CDK10 silencing in
CC       increasing c-Raf and in conferring tamoxifen resistance to breast
CC       cancer cells.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin-like FAM58 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH01909.4; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH07232.4; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH32121.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH71851.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC001909; AAH01909.4; ALT_INIT; mRNA.
DR   EMBL; BC007232; AAH07232.4; ALT_INIT; mRNA.
DR   EMBL; BC032121; AAH32121.1; ALT_INIT; mRNA.
DR   EMBL; BC071851; AAH71851.1; ALT_INIT; mRNA.
DR   EMBL; DQ323993; ABC88595.1; -; mRNA.
DR   EMBL; AY445048; AAS20614.1; -; mRNA.
DR   CCDS; CCDS76054.1; -. [Q8N1B3-2]
DR   RefSeq; NP_001124469.1; NM_001130997.2. [Q8N1B3-2]
DR   RefSeq; NP_689487.2; NM_152274.4. [Q8N1B3-1]
DR   AlphaFoldDB; Q8N1B3; -.
DR   SMR; Q8N1B3; -.
DR   BioGRID; 124901; 19.
DR   ComplexPortal; CPX-326; Cyclin M-CDK10 complex.
DR   IntAct; Q8N1B3; 16.
DR   MINT; Q8N1B3; -.
DR   STRING; 9606.ENSP00000402949; -.
DR   iPTMnet; Q8N1B3; -.
DR   PhosphoSitePlus; Q8N1B3; -.
DR   BioMuta; CCNQ; -.
DR   DMDM; 156630447; -.
DR   EPD; Q8N1B3; -.
DR   jPOST; Q8N1B3; -.
DR   MassIVE; Q8N1B3; -.
DR   MaxQB; Q8N1B3; -.
DR   PaxDb; Q8N1B3; -.
DR   PeptideAtlas; Q8N1B3; -.
DR   PRIDE; Q8N1B3; -.
DR   ProteomicsDB; 71580; -. [Q8N1B3-1]
DR   ProteomicsDB; 71581; -. [Q8N1B3-2]
DR   Antibodypedia; 73523; 29 antibodies from 12 providers.
DR   DNASU; 92002; -.
DR   Ensembl; ENST00000440428.5; ENSP00000402949.2; ENSG00000262919.8. [Q8N1B3-2]
DR   Ensembl; ENST00000576892.8; ENSP00000461135.1; ENSG00000262919.8. [Q8N1B3-1]
DR   GeneID; 92002; -.
DR   KEGG; hsa:92002; -.
DR   MANE-Select; ENST00000576892.8; ENSP00000461135.1; NM_152274.5; NP_689487.2.
DR   UCSC; uc033fat.2; human. [Q8N1B3-1]
DR   CTD; 92002; -.
DR   DisGeNET; 92002; -.
DR   GeneCards; CCNQ; -.
DR   HGNC; HGNC:28434; CCNQ.
DR   HPA; ENSG00000262919; Low tissue specificity.
DR   MalaCards; CCNQ; -.
DR   MIM; 300707; phenotype.
DR   MIM; 300708; gene.
DR   neXtProt; NX_Q8N1B3; -.
DR   OpenTargets; ENSG00000262919; -.
DR   Orphanet; 140952; Syndactyly-telecanthus-anogenital and renal malformations syndrome.
DR   PharmGKB; PA142671863; -.
DR   VEuPathDB; HostDB:ENSG00000262919; -.
DR   eggNOG; KOG0834; Eukaryota.
DR   GeneTree; ENSGT00940000155445; -.
DR   HOGENOM; CLU_022000_2_0_1; -.
DR   InParanoid; Q8N1B3; -.
DR   OMA; FDTHVAL; -.
DR   OrthoDB; 958680at2759; -.
DR   PhylomeDB; Q8N1B3; -.
DR   PathwayCommons; Q8N1B3; -.
DR   SignaLink; Q8N1B3; -.
DR   BioGRID-ORCS; 92002; 24 hits in 179 CRISPR screens.
DR   ChiTaRS; FAM58A; human.
DR   GenomeRNAi; 92002; -.
DR   Pharos; Q8N1B3; Tdark.
DR   PRO; PR:Q8N1B3; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q8N1B3; protein.
DR   Bgee; ENSG00000262919; Expressed in tendon of biceps brachii and 180 other tissues.
DR   ExpressionAtlas; Q8N1B3; baseline and differential.
DR   Genevisible; Q8N1B3; HS.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IPI:ComplexPortal.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IBA:GO_Central.
DR   GO; GO:1902749; P:regulation of cell cycle G2/M phase transition; IDA:ComplexPortal.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd00043; CYCLIN; 1.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR028759; Cyclin-Q.
DR   InterPro; IPR043198; Cyclin/Ssn8.
DR   InterPro; IPR006671; Cyclin_N.
DR   PANTHER; PTHR10026; PTHR10026; 1.
DR   PANTHER; PTHR10026:SF70; PTHR10026:SF70; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cyclin; Reference proteome.
FT   CHAIN           1..248
FT                   /note="Cyclin-Q"
FT                   /id="PRO_0000297567"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   VAR_SEQ         219..238
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_034527"
FT   VARIANT         183
FT                   /note="C -> S (in dbSNP:rs17850173)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_034642"
SQ   SEQUENCE   248 AA;  28369 MW;  E7C11BC5D23BFB82 CRC64;
     MEAPEGGGGG PAARGPEGQP APEARVHFRV ARFIMEAGVK LGMRSIPIAT ACTIYHKFFC
     ETNLDAYDPY LIAMSSIYLA GKVEEQHLRT RDIINVSNRY FNPSGEPLEL DSRFWELRDS
     IVQCELLMLR VLRFQVSFQH PHKYLLHYLV SLQNWLNRHS WQRTPVAVTA WALLRDSYHG
     ALCLRFQAQH IAVAVLYLAL QVYGVEVPAE VEAEKPWWQV FNDDLTKPII DNIVSDLIQI
     YTMDTEIP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024